Shopping Cart
- Remove All
- Your shopping cart is currently empty
Gln-AMS(TFA) inhibits glutaminyl-tRNA synthetase (GlnRS) with a Ki of 1.32 μM. Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $486 | Backorder | |
10 mg | $750 | Backorder | |
25 mg | $1,542 | Backorder | |
50 mg | $2,421 | Backorder | |
100 mg | $3,476 | Backorder | |
200 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder | |
1 mL x 10 mM (in DMSO) | $629 | Backorder |
Description | Gln-AMS(TFA) inhibits glutaminyl-tRNA synthetase (GlnRS) with a Ki of 1.32 μM. Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. |
Targets&IC50 | GlnRS:ki: 1.32 µM |
In vitro | Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. |
Alias | Gln-AMS TFA |
Molecular Weight | 588.47 |
Formula | C17H23F3N8O10S |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (169.93 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.